Scientists Find Link Between Statin Use and Reduced Risk of Age-Related Frailty 0 10

The results of the study were published in the European Heart Journal. Researchers examined data from nearly one million elderly individuals, with an average follow-up of 63 months.

During this period, some participants began taking statins—medications widely used to lower cholesterol levels and prevent cardiovascular diseases.

After accounting for factors such as body weight, smoking, presence of chronic diseases, and other health characteristics, the researchers discovered an interesting pattern. Among elderly individuals who started statin therapy, the risk of developing age-related frailty was found to be 24% lower compared to those who did not take these medications.

Age-related frailty is considered one of the most serious geriatric syndromes. It manifests as a decrease in muscle strength, increased fatigue, reduced physical activity, and greater vulnerability to diseases and injuries.

The authors of the study suggest that the identified link may be due not only to the effect of statins on cholesterol levels. According to the researchers, the anti-inflammatory action of these medications may also play a role, as chronic inflammation is considered one of the factors associated with aging and the development of age-related frailty.

At the same time, the scientists emphasize that the study was observational in nature. This means that the results demonstrate a statistical association but do not allow for the conclusion that statin use directly prevents the development of age-related frailty.

The data obtained indicate a possible additional benefit of statins for older adults. However, specialists stress that such medications should only be prescribed based on medical indications and after consultation with a doctor. Further clinical studies are needed to confirm the protective effect.

The observation lasted for 63 months. During this period, some participants began taking statins—these agents are typically used to lower cholesterol and prevent cardiovascular diseases.

After considering weight, smoking, comorbidities, and other factors, the researchers found that elderly individuals who started statin therapy had a 24% lower risk of age-related frailty.

The authors of the study suggest that such a link may also be explained by the anti-inflammatory effects of these medications. However, since the study was observational, its results do not prove that statins directly protect against age-related frailty.